Hopfner, Franziska http://orcid.org/0000-0001-6524-0281
Buhmann, Carsten
Classen, Joseph
Holtbernd, Florian
Klebe, Stephan
Koschel, Jiri
Kohl, Zacharias
Paus, Sebastian
Pedrosa, David J.
Funding for this research was provided by:
Klinikum der Universität München
Article History
Received: 9 April 2024
Accepted: 4 July 2024
First Online: 24 July 2024
Declarations
:
: Franziska Hopfner is funded by the DFG, the Erwin Röver Stiftung and the CurePSP Foundation and receives author fees from Thieme medical publishers and W. Kohlhammer GmbH medical publishers. Carsten Buhmann received royalties from Thieme medical publishers and W. Kohlhammer GmbH medical publishers and fees for lectures and/or honour boards from AbbVie, Bial, Desitin, Kyowa Kirin, Merz, STADA Pharma, TAD Pharma, UCB, and Zambon. Stephan Klebe received honoraria for lectures from Esteve Pharma, Ipsen, AbbVie, Roche, Stadapharm and Bial. Joseph Classen receives or has received funding from DFG, BMBF, royalties from Thieme medical publishers and W. Kohlhammer GmbH medical publishers; honoraria for lectures from AbbVie, Bayer, BIAL, Biogen, Desitin Arzneimittel GmbH, Roche, UCB Pharma, Zambon. David Pedrosa is funded by the European Commission, EITHEalth and the Reinfried Pohl-Stiftung. David Pedrosa received honoraria as a speaker at symposia sponsored by Bial, Boston Scientific Corp., Medtronic, AbbVie Inc., Zambon, and Esteve Pharmaceuticals GmbH. He received payments as a consultant for Boston Scientific Corp and Bayer, and he was awarded a scientific scholarship from Boston Scientific Corp. for a project titled "Sensor-based optimization of Deep Brain Stimulation settings in Parkinson's disease". David Pedrosa had his travel expenses reimbursed by Esteve Pharmaceuticals GmbH and Boston Scientific Corp for attending conferences. Florian Holtbernd has received funding from the DFG and the RWTH Aachen University. He has received travel and conference fees from Abbvie, Bial, Desitin, Abbott, and Zambon. Jiri Koschel has received travel and conference fees from Desitin, Bial Medronic and Zambon. Zacharias Kohl received honoraria for lectures from AbbVie, BIAL, Pfizer, Desitin Arzneimittel GmbH, Stadapharm and Novartis.